Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Companyâ€™s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Companyâ€™s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Companyâ€™s main shareholder is Nordnet Pensionsforsakring.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
18/06/26	0.2320 kr	+3.11%	572,559
17/06/26	0.2250 kr	+2.74%	773,774
16/06/26	0.2190 kr	+2.82%	611,347
15/06/26	0.2130 kr	+9.23%	293,858
12/06/26	0.1950 kr	-4.41%	132,222

End-of-day quote SPOTLIGHT STOCK MARKET AB

More quotes

Income Statement and Estimates

More financial data

Net sales - Rate of surprise

Company calendar

End-of-day quote SPOTLIGHT STOCK MARKET AB Other stock markets 18/06/2026			5-day change	1st Jan Change
0.2320 ^SEK	+3.11%		+18.97%	-94.65%

06-16	Inhalation Sciences Secures SEK 0.4m Research Grant	FW
05-29	Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall	FW

Market Cap	11.88M 1.24M 1.08M 1M 937K 1.76M 117M 1.77M 4.6M 57.59M 4.65M 4.55M 200M	P/E 2024	-12.8x	P/E 2025	-12.4x
Enterprise Value	9.05M 944K 823K 763K 714K 1.34M 89.11M 1.35M 3.51M 43.86M 3.54M 3.47M 152M	EV / Sales 2024	5.6x	EV / Sales 2025	55x
Free-Float	94.25%	Yield 2024 *	-	Yield 2025	-

06-16	Inhalation Sciences Secures SEK 0.4m Research Grant	FW
05-29	Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall	FW
05-27	Inhalation Sciences working to secure additional funding	FW
05-18	Inhalation Sciences Sweden Wins Inhalation Research Services Order	MT
05-18	Inhalation Sciences secures order worth approximately SEK 1.3 million	FW
05-18	Inhalation Sciences Sweden AB Receives IRS Order Worth Approximately EUR 117,000	CI
05-11	Inhalation Sciences posts revenue and order intake growth in Q1	FW
05-11	Inhalation Sciences Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-24	Inhalation Sciences secures order worth SEK 350,000	FW
03-24	Inhalation Sciences Sweden AB Secures Additional PreciseInhale Service Orders Worth SEK 350,000	CI
03-03	Inhalation Sciences Raises SEK 2.88 Million Through Warrant Exercise and Directed Share Issue	FW
02-27	Inhalation Sciences Sees Decline in Revenue and Operating Profit – Starts 2026 with Strong Order Backlog	FW
02-27	Inhalation Sciences Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

05-18	Inhalation Sciences receives IRS order worth approximately EUR 117,000	AQ
03-24	Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	PU
03-24	Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	AQ
02-18	Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000	AQ
01-27	Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies	PU

Inhalation Sciences Sweden AB Stock

Stocks

ISAB

SE0009983893

Advanced Medical Equipment & Technology

Valuation: Inhalation Sciences Sweden AB

Chart: Inhalation Sciences Sweden AB

Latest news : Inhalation Sciences Sweden AB

Press Releases: Inhalation Sciences Sweden AB

Quotes and Performance

Course Extremes

Managers and Directors: Inhalation Sciences Sweden AB

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Net sales - Rate of surprise

1 day	+3.11%
1 week	+18.97%
Current month	-1.28%
1 month	-12.45%
3 months	-2.52%
6 months	-94.65%
Current year	-94.65%

1 week	0.19	0.24
1 month	0.19	0.5
Current year	0.17	0.58
1 year	0.17	0.58
3 years	0.17	4.99
5 years	0.17	11.3
10 years	0.17	15.48

Manager	Title	Age	Since
Manoush Masarrat CEO	Chief Executive Officer	-	16/09/2019
Per Magnus Gerde CTO	Chief Tech/Sci/R&D Officer	-	01/01/2005
Ulf Wedenberg PRN	Corporate Officer/Principal	-	02/06/2025

Director	Title	Age	Since
Per Magnus Gerde BRD	Director/Board Member	-	01/01/2005
Jan Hellqvist BRD	Director/Board Member	-	01/09/2022
Ulf Ericsson BRD	Director/Board Member	-	01/09/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INHALATION SCIENCES SWEDEN AB	+3.11%	+18.97%	-94.65%	-91.71%	1.24M
THERMO FISHER SCIENTIFIC, INC.	+0.63%	-1.01%	+16.77%	-11.91%	173B
INTUITIVE SURGICAL, INC.	+1.14%	-1.04%	-20.14%	+24.08%	144B
DANAHER CORPORATION	-0.33%	-1.63%	-9.79%	-25.12%	125B
BOSTON SCIENTIFIC CORPORATION	+0.76%	-3.45%	-55.29%	-16.19%	67.32B
EDWARDS LIFESCIENCES CORPORATION	+0.78%	+2.64%	+18.33%	-4.95%	50.3B
SIEMENS HEALTHINEERS AG	-0.58%	-1.16%	-25.96%	-32.99%	43.8B
AGILENT TECHNOLOGIES, INC.	+2.20%	-2.14%	+9.95%	+7.53%	35.89B
WATERS CORPORATION	-0.44%	-0.03%	+3.74%	+35.01%	34.9B
GE HEALTHCARE TECHNOLOGIES INC.	+0.72%	-5.51%	-13.59%	-21.94%	28.02B
Average	+0.80%	+0.22%	-17.06%	-13.82%	70.23B
Weighted average by Cap.	+0.54%	-1.89%	-7.21%	-5.19%

	2024	2025
Net sales	11.05M 1.15M 1.01M 931K 872K 1.63M 109M 1.64M 4.28M 53.56M 4.33M 4.24M 186M	3.04M 317K 277K 256K 240K 450K 29.95M 453K 1.18M 14.74M 1.19M 1.17M 51.19M
Net income	-5.15M -537K -468K -434K -406K -762K -50.7M -766K -1.99M -24.95M -2.02M -1.97M -86.65M	-10.16M -1.06M -925K -856K -802K -1.5M -100M -1.51M -3.94M -49.26M -3.98M -3.9M -171M
Net Debt	-4M -418K -364K -337K -316K -592K -39.43M -596K -1.55M -19.41M -1.57M -1.53M -67.39M	-2.83M -296K -258K -239K -223K -419K -27.88M -421K -1.1M -13.73M -1.11M -1.09M -47.66M